FDA Approves Frequent Urination OTC Treatment
By Charles Poladian | February 2, 2013 6:36 AM EST
The Food and Drug Administration announced the approval of an Over the Counter treatment for frequent urination, also known as overactive bladder. On Friday, Oxytrol was approved for use by women over the age of 18.
The FDA announced its approval of Oxytrol, the first OTC to treat frequent urination on January 25. According to the FDA, overactive bladder is “a condition in which the bladder squeezes too often or squeezes without warning. Symptoms include leaking urine (urinary incontinence), feeling the sudden and urgent need to urinate, and frequent urination. Overactive bladder affects an estimated 33 million Americans, the majority of whom are older women.”
Oxytrol works by relaxing the bladder muscle due to the main drug, oxybutynin, which reduces the squeezing and relieve the symptoms of frequent urination. Oxytrol is applied via a patch once every four days which delivers 3.9 milligrams of oxybutynin daily. The FDA said Oxytrol was a safe and effective treatment for overactive bladder.
While women can purchase Oxytrol without a prescription, the same won’t be true for men who have frequent urination. Oxytrol will only be available for men by prescription only.
The FDA gave its approval of Oxytrol following the evaluation of nine different studies that involved 5,000 people which determined the treatment was easy to use and the application process was easy to understand. Side effects for Oxytrol during the trials were minimal and included “skin irritation where the patch was applied, dry mouth and constipation.”
Oxytrol is manufactured by Merck who plans to release the OTC treatment in the fall, reports Yahoo!. This is the second overactive bladder treatment that has been approved by the FDA in the last two weeks.
On January 18, the FDA approved Botox injections to treat overactive bladder and frequent urination for individuals who do not respond well to anticholinergics, a class of drugs in which Oxytrol belongs to. Much like Oxytrol, Botox injections will cause the bladder to relax and relieve frequent urination and urinary incontinence. According to Hylton V. Joffe, M.D., director of the Division of Reproductive and Urologic Products in FDA’s Center for Drug Evaluation and Research, “Clinical studies have demonstrated Botox’s ability to significantly reduce the frequency of urinary incontinence.”
To contact the editor, e-mail:
Most Popular Slideshows
- Still The World Champions: Team USA Overpowers Serbia, 129-92 To Win 2014 FIBA World Cup [PHOTOS]
- Kendall Jenner Could Be Next Victoria's Secret Angel [PHOTOS]
- From Fat To Fit: Celebrities Who Were Overweight Before They Became The Beauties That They Are
- Taylor Swift Named People's Best Dressed Stars Of 2014 [PHOTOS]
Join the Conversation
- Headache: Rx – Sex 3X A Day
- Bardarbunga Volcano In Iceland Erupts With Brightly Coloured Lava Under Northern Lights [Watch Video]
- A Jawbone Found In Sydney Beach Has Been Matched To An 800-Year Old Skull
- George, The Goldfish Underwent Surgery To Remove Brain Tumour - Watch Video
- Kylie Jenner Wants To Quit Modelling To Be A Singer As She Thinks She Is The 'New Katy Perry'; Reasons Why People Switch Careers
- iOS 8 Release Date Of Sept 17 Has Arrived: Update Begins At 10AM Pacific Time, Upgrade Your iDevices With iOS 7.1.2 First To Install iOS 8
- Why Samsung Galaxy S5 Is Not The Best Smartphone To Purchase Now? If You Still Want To, Wait For A Month To Get It Cheap
- Apple iPad Air 2, iPad Mini 3 October Release Date Roundup: Freshly Leaked Protective Case Debuts Unique Vent Alongside Camera
- Canadian IS Jihadist Wants to ‘Play Soccer’ with Heads of US Decapitated Soldiers
- Google Nexus 6 Release Date on Q4 2014 Confirmed by T-Mobile Featuring Wi-Fi Calling
- Warning to U.S. – ISIS Has Shot Down a Syrian Regime Fighter Jet
- Spice Dream Uno vs Xiaomi Redmi 1S: Android One Smartphone to Challenge The Existing Budget Friendly Smartphone